Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Broadcom
AVGO
|
+$1.43B |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$805M |
| 3 |
Meta Platforms (Facebook)
META
|
+$713M |
| 4 |
Amazon
AMZN
|
+$688M |
| 5 |
Tesla
TSLA
|
+$525M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.96B |
| 2 |
Spotify
SPOT
|
+$1.22B |
| 3 |
Microsoft
MSFT
|
+$847M |
| 4 |
Apollo Global Management
APO
|
+$757M |
| 5 |
Workday
WDAY
|
+$444M |
Sector Composition
| 1 | Technology | 15.78% |
| 2 | Financials | 14.57% |
| 3 | Healthcare | 12.51% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Discretionary | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
1926
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.72M | ﹤0.01% |
1,551,372
+1,403,562
| +950% | +$4.27M |
|
1927
Interparfums
IPAR
$3.43B
| $4.7M | ﹤0.01% |
35,757
-17,044
| -32% | -$2.24M |
|
1928
Sprinklr
CXM
$1.88B
| $4.7M | ﹤0.01% |
555,752
+129,256
| +30% | +$1.09M |
|
1929
Essent Group
ESNT
$6.29B
| $4.69M | ﹤0.01% |
86,087
+58,768
| +215% | +$3.2M |
|
1930
White Mountains Insurance
WTM
$4.54B
| $4.67M | ﹤0.01% |
2,401
+2,007
| +509% | +$3.9M |
|
1931
Kymera Therapeutics
KYMR
$3.36B
| $4.66M | ﹤0.01% |
115,918
+77,912
| +205% | +$3.13M |
|
1932
Pyxis Oncology
PYXS
$113M
| $4.65M | ﹤0.01% |
2,980,906
+1,073,928
| +56% | +$1.68M |
|
1933
Humacyte
HUMA
$233M
| $4.64M | ﹤0.01% |
918,854
-348,653
| -28% | -$1.76M |
|
1934
Kimball Electronics
KE
$741M
| $4.63M | ﹤0.01% |
247,408
-80,043
| -24% | -$1.5M |
|
|
CDMO
1935
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $4.63M | ﹤0.01% |
375,049
-3,813,954
| -91% | -$47.1M |
|
1936
RLI Corp
RLI
$6.14B
| $4.61M | ﹤0.01% |
55,992
-214,146
| -79% | -$17.6M |
|
1937
Nu Skin
NUS
$596M
| $4.6M | ﹤0.01% |
668,128
-628,462
| -48% | -$4.33M |
|
1938
Iris Energy
IREN
$9.24B
| $4.6M | ﹤0.01% |
468,412
-1,356,099
| -74% | -$13.3M |
|
1939
Merchants Bancorp
MBIN
$1.5B
| $4.6M | ﹤0.01% |
126,087
+85,948
| +214% | +$3.13M |
|
1940
eXp World Holdings
EXPI
$1.75B
| $4.6M | ﹤0.01% |
399,402
-499,397
| -56% | -$5.75M |
|
1941
Inter&Co
INTR
$3.92B
| $4.59M | ﹤0.01% |
+1,086,740
| New | +$4.59M |
|
1942
Autohome
ATHM
$3.48B
| $4.57M | ﹤0.01% |
175,920
-93,307
| -35% | -$2.42M |
|
1943
Corbus Pharmaceuticals
CRBP
$116M
| $4.56M | ﹤0.01% |
386,653
+283,902
| +276% | +$3.35M |
|
1944
Halozyme
HALO
$8.99B
| $4.56M | ﹤0.01% |
95,424
+68,505
| +254% | +$3.28M |
|
1945
Littelfuse
LFUS
$6.54B
| $4.54M | ﹤0.01% |
19,253
+17,128
| +806% | +$4.04M |
|
1946
Unisys
UIS
$282M
| $4.54M | ﹤0.01% |
716,541
+61,766
| +9% | +$391K |
|
1947
Lindblad Expeditions
LIND
$735M
| $4.53M | ﹤0.01% |
381,900
-127,464
| -25% | -$1.51M |
|
|
VCIC
1948
Vine Hill Capital Investment Corp. Class A Ordinary Shares
VCIC
$309M
| $4.52M | ﹤0.01% |
+450,000
| New | +$4.52M |
|
1949
Grupo Aeroportuario del Sureste
ASR
$10.4B
| $4.52M | ﹤0.01% |
17,553
+10,778
| +159% | +$2.78M |
|
1950
GeneDx Holdings
WGS
$3.56B
| $4.52M | ﹤0.01% |
58,803
-515,633
| -90% | -$39.6M |
|